7 unknown, 2 completed, 2 recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 2, Recruiting 1 |
Follow Qin Ning: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Case-control Study on the Clinical Characteristics of 28-day and 90-day Death From Severe Anthrax Anthrax | Unknown | Qin Ning | 80 | 2024-03-13 | 2024-04-15 | |
| Clinical Observation of CABA System in the Treatment of End-stage Liver Disease With Inflammation New artificial liver CABA system (BS330+CA280) +PE - To Evaluate the Clinical Efficacy and Safety of the New ALSS | Phase 4 | Recruiting | Qin Ning | 40 | 2023-03-10 | 2026-10-15 |
| Study on Prognosis of Acute-on-chronic Liver Failure Complicated by Bacterial or Fungal Infection Acute-On-Chronic Liver Failure | Unknown | Qin Ning | 400 | 2023-03-01 | 2024-05-31 | |
| Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS) Methylprednisolone, intravenous immunoglobulin, Tocilizumab - Severe Fever With Thrombocytopenia Syndrome | Phase 4 | Unknown | Qin Ning | 350 | 2022-08-19 | 2023-07-21 |
| A Multicentre, Retrospective Study of Clinical Characteristics and Long-term Outcomes of Patients With Brucellosis Brucellosis | Completed | Qin Ning | 200 | 2022-04-27 | 2023-08-23 | |
| A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease. the Effect of NAFLD on CHB | Recruiting | Qin Ning | 10000 | 2022-02-24 | 2022-02-25 | |
| Follow-up Study of Population Vaccinated With COVID-19 Vaccine Healthy | Unknown | Qin Ning | 1000 | 2021-03-15 | 2021-07-22 | |
| A Study of AARC Standards on Diagnosis and Treatment of Patients With HBV-ACLF in China (AARC China Study) No intervention - Acute on Chronic Liver Failure, HBV | Unknown | Qin Ning | 3000 | 2019-07-02 | 2019-08-13 | |
| A Study of MHE in Patients With Liver Diseases neurophysiological tests, blood biomarkers. - Hepatic Encephalopathy, Minimal Hepatic Encephalopathy | Completed | Qin Ning | 252 | 2019-05-01 | 2024-06-17 | |
| A Prospective,Observational Follow-up Study of Nucleoside Treated Patients With Chronic Hepatitis B (OCEAN Study) Hepatitis B, Chronic | Unknown | Qin Ning | 1600 | 2018-02-27 | 2018-10-19 | |
| Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients Entecavir, Granulocyte Macrophage Colony Stimulating Factor, Y peginterferon alfa-2b - Chronic Hepatitis b | Phase 4 | Unknown | Qin Ning | 15 | 2015-12-01 | 2017-11-06 |
Acute-On-Chronic Liver Failure (3) · Disease (2) · Hepatitis B, Chronic (2) · Anthrax (1) · Brucellosis (1) · COVID-19 (1) · Hepatic Encephalopathy (1) · Liver Cirrhosis (1) · Severe Fever with Thrombocytopenia Syndrome (1)
Granulocyte-Macrophage Colony-Stimulating Factor (1) · Heparin, Low-Molecular-Weight (1) · Immunoglobulins, Intravenous (1) · Methylprednisolone (1) · Vaccines (1) · entecavir (1) · tocilizumab (1)
China (10)
Ning Qin, Doctor (1) · Qin Qin, MD., PhD (1)